| |
| |
|
| Insider
Information: |
Kozarich John W |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
128,523 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,172,316 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
128,523 |
|
|
| Total
Value |
$3,172,316 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -27.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-24 |
42,523 |
2006-01-04 |
0 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
Director |
2015-06-29 |
57,000 |
2013-05-13 |
0 |
Premium* |
|
|
Travere Therapeutics, Inc |
TVTX |
Director |
2019-05-08 |
29,000 |
2015-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2024-04-24 |
4 |
OE |
$39.35 |
$113,840 |
D/D |
2,893 |
42,523 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,142 |
39,630 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2023-05-16 |
4 |
S |
$77.20 |
$343,081 |
D/D |
(4,444) |
38,488 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2023-05-08 |
4 |
S |
$76.51 |
$490,628 |
D/D |
(6,408) |
42,213 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2023-05-08 |
4 |
OE |
$18.82 |
$120,599 |
D/D |
6,408 |
48,621 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,004 |
42,213 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-02-28 |
4 |
S |
$102.62 |
$93,179 |
D/D |
(908) |
41,209 |
0 |
% |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2022-02-28 |
4 |
OE |
$12.53 |
$91,908 |
D/D |
7,335 |
42,117 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2021-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
630 |
34,782 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2021-05-11 |
4 |
OE |
$10.12 |
$48,930 |
D/D |
4,835 |
34,543 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2021-05-11 |
4 |
D |
$128.56 |
$50,267 |
D/D |
(391) |
34,152 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2021-02-22 |
4 |
OE |
$10.12 |
$25,300 |
D/D |
2,500 |
29,708 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
831 |
27,208 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
26,377 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-05-14 |
4 |
S |
$112.92 |
$282,300 |
D/D |
(2,500) |
25,542 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2019-05-14 |
4 |
OE |
$17.88 |
$44,700 |
D/D |
2,500 |
28,042 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2019-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,000 |
29,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-10-01 |
4 |
AS |
$275.04 |
$687,610 |
D/D |
(2,500) |
26,142 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-07-02 |
4 |
AS |
$207.48 |
$518,699 |
D/D |
(2,500) |
28,642 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
31,142 |
0 |
- |
|
| TVTX |
Travere Therapeutics, Inc |
Director |
– • – |
2018-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
27,000 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-04-02 |
4 |
AS |
$160.43 |
$401,063 |
D/D |
(2,500) |
30,649 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2018-01-10 |
4 |
AS |
$145.00 |
$362,500 |
D/D |
(2,500) |
33,149 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-11-16 |
4 |
S |
$141.71 |
$708,550 |
D/D |
(5,000) |
35,649 |
0 |
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
666 |
40,649 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
